Showing 1 - 20 results of 27 for search 'Alexander T.H. Wu', query time: 0.09s Refine Results
  1. 1
    Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule

    Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule by Bashir Lawal, Bashir Lawal, Alexander T. H. Wu, Alexander T. H. Wu, Alexander T. H. Wu, Alexander T. H. Wu, Hsu-Shan Huang, Hsu-Shan Huang, Hsu-Shan Huang, Hsu-Shan Huang, Hsu-Shan Huang

    Published 2022-05-01
    Get full text
    Article
  2. 2
    Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives

    Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Ph... by Bashir Lawal, Bashir Lawal, Yu-Chi Wang, Alexander T. H. Wu, Alexander T. H. Wu, Alexander T. H. Wu, Alexander T. H. Wu, Hsu-Shan Huang, Hsu-Shan Huang, Hsu-Shan Huang, Hsu-Shan Huang, Hsu-Shan Huang

    Published 2021-08-01
    Get full text
    Article
  3. 3
    The intricate interplay between cancer stem cells and cell-of-origin of cancer: implications for therapeutic strategies

    The intricate interplay between cancer stem cells and cell-of-origin of cancer: implications for therapeutic strategies by Oluwaseun Adebayo Bamodu, Oluwaseun Adebayo Bamodu, Chen-Chih Chung, Chen-Chih Chung, Chen-Chih Chung, Thomas R. Pisanic, Thomas R. Pisanic, Thomas R. Pisanic, Alexander T. H. Wu, Alexander T. H. Wu, Alexander T. H. Wu, Alexander T. H. Wu

    Published 2024-05-01
    Get full text
    Article
  4. 4
    Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration

    Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target thera... by Ming-Lang Shih, Bashir Lawal, Bashir Lawal, Sheng-Yao Cheng, Janet O. Olugbodi, Ahmad O Babalghith, Ching-Liang Ho, Simona Cavalu, Gaber El-Saber Batiha, Sarah Albogami, Saqer S. Alotaibi, Jih-Chin Lee, Alexander T. H. Wu, Alexander T. H. Wu, Alexander T. H. Wu, Alexander T. H. Wu

    Published 2022-08-01
    Get full text
    Article
  5. 5
    mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications

    mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implicat... by Bashir Lawal, Bashir Lawal, Ching-Yu Lee, Ching-Yu Lee, Ntlotlang Mokgautsi, Ntlotlang Mokgautsi, Maryam Rachmawati Sumitra, Maryam Rachmawati Sumitra, Harshita Khedkar, Harshita Khedkar, Alexander T.H. Wu, Alexander T.H. Wu, Alexander T.H. Wu, Alexander T.H. Wu, Hsu-Shan Huang, Hsu-Shan Huang, Hsu-Shan Huang, Hsu-Shan Huang, Hsu-Shan Huang

    Published 2021-03-01
    Get full text
    Article
  6. 6
    In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates

    In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates by Bashir Lawal, Sheng-Kuang Tsai, Alexander T.H. Wu, Hsu-Shan Huang

    Published 2023-05-01
    Get full text
    Article
  7. 7
    Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects

    Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects by Tse-Hung Huang, Ntlotlang Mokgautsi, Yan-Jiun Huang, Alexander T. H. Wu, Hsu-Shan Huang

    Published 2021-08-01
    Get full text
    Article
  8. 8
    In Silico Evaluation of HN-N07 Small Molecule as an Inhibitor of Angiogenesis and Lymphangiogenesis Oncogenic Signatures in Non-Small Cell Lung Cancer

    In Silico Evaluation of HN-N07 Small Molecule as an Inhibitor of Angiogenesis and Lymphangiogenesis Oncogenic Signatures in Non-Small Cell Lung Cancer by Lung-Ching Chen, Ntlotlang Mokgautsi, Yu-Cheng Kuo, Alexander T. H. Wu, Hsu-Shan Huang

    Published 2023-07-01
    Get full text
    Article
  9. 9
    MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types

    MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types by Szu-Yuan Wu, Kuan-Chou Lin, Bashir Lawal, Alexander T.H Wu, Ching-Zong Wu

    Published 2021-01-01
    Get full text
    Article
  10. 10
    Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate

    Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate by Alexander T. H. Wu, Bashir Lawal, Li Wei, Ya-Ting Wen, David T. W. Tzeng, Wen-Cheng Lo

    Published 2021-09-01
    Get full text
    Article
  11. 11
    Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer

    Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer by Ntlotlang Mokgautsi, Yu-Cheng Kuo, Chien-Hsin Chen, Yan-Jiun Huang, Alexander T. H. Wu, Hsu-Shan Huang

    Published 2023-01-01
    Get full text
    Article
  12. 12
    Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines

    Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines by Bashir Lawal, Yen-Lin Liu, Ntlotlang Mokgautsi, Harshita Khedkar, Maryam Rachmawati Sumitra, Alexander T. H. Wu, Hsu-Shan Huang

    Published 2021-01-01
    Get full text
    Article
  13. 13
    Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures

    Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures by Ntlotlang Mokgautsi, Yu-Cheng Kuo, Yan-Jiun Huang, Chien-Hsin Chen, Debabrata Mukhopadhyay, Alexander T. H. Wu, Hsu-Shan Huang

    Published 2023-01-01
    Get full text
    Article
  14. 14
    Structure-based strategies for synthesis, lead optimization and biological evaluation of N-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as potential multi-target anticancer agents

    Structure-based strategies for synthesis, lead optimization and biological evaluation of N-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as potential multi-tar... by Ahmed Atef Ahmed Ali, Yu-Ru Lee, Alexander T.H. Wu, Vijesh Kumar Yadav, Dah-Shyong Yu, Hsu-Shan Huang

    Published 2021-02-01
    Get full text
    Article
  15. 15
    Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration

    Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration by Bashir Lawal, Yu-Cheng Kuo, Sung-Ling Tang, Feng-Cheng Liu, Alexander T. H. Wu, Hung-Yun Lin, Hsu-Shan Huang

    Published 2021-10-01
    Get full text
    Article
  16. 16
    A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling

    A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling by Alexander T. H. Wu, Hsu-Shan Huang, Ya-Ting Wen, Bashir Lawal, Ntlotlang Mokgautsi, Thanh-Tuan Huynh, Michael Hsiao, Li Wei

    Published 2021-09-01
    Get full text
    Article
  17. 17
    Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues

    Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues by Hsin-Hsien Yu, Edward Chengchuan KO, Chia-Lun Chang, Kevin Sheng-Po Yuan, Alexander T. H. Wu, Yan-Shen Shan, Szu-Yuan Wu

    Published 2018-10-01
    Get full text
    Article
  18. 18
    Biomechanical comparison of four tibial fixation techniques for meniscal root sutures in posterior medial meniscus root repair: A porcine study

    Biomechanical comparison of four tibial fixation techniques for meniscal root sutures in posterior medial meniscus root repair: A porcine study by Shen-Han Wu, Tsu-Te Yeh, Wei-Chun Hsu, Alexander T.H. Wu, Guoan Li, Chih-Hwa Chen, Chian-Her Lee, Jia-Lin Wu

    Published 2020-09-01
    Get full text
    Article
  19. 19
    Structure-based design, synthesis and biological evaluation of N-substituted 6H-thiochromeno[2,3–c]quinolin-12(12H)-one as potential breast cancer drugs

    Structure-based design, synthesis and biological evaluation of N-substituted 6H-thiochromeno[2,3–c]quinolin-12(12H)-one as potential breast cancer drugs by Maryam Rachmawati Sumitra, Lung-Ching Chen, Wei-Chen Tsai, Muhamad Ansar, Bashir Lawal, Ntlotlang Mokgautsi, Jih-Hwa Guh, Alexander T.H Wu, Hsu-Shan Huang

    Published 2024-01-01
    Get full text
    Article
  20. 20
    Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer

    Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer by Kuo-Chang Wen, Pi-Lin Sung, Alexander T. H. Wu, Ping-Chieh Chou, Jun-Hung Lin, Chi-Ying F. Huang, Sai-Ching J. Yeung, Mong-Hong Lee

    Published 2020-08-01
    Get full text
    Article

Search Tools: